Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation
Access to pharmaceutical products worsened during the COVID-19 pandemic when key developers of active pharmaceutical ingredients and medicinal products prioritised their national markets. These challenges led to a stronger commitment by the European Union (EU) to become more autonomous in developing...
Saved in:
Main Authors: | Berner-Rodoreda, Astrid, Cobelens, Frank, Vandamme, Anne-Mieke, Froeschi, Gunter, Skordis, Jolene, Elil, Renganathan *, t'Hoen, Ellen, Raviglione, Mario, Jahn, Albrecht, Barnighausen, Till |
---|---|
Format: | Article |
Published: |
BMJ Publishing Group
2024
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/2608/ https://doi.org/10.1136/bmjgh-2023-014605 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fiqh Behind the Halal Pharma Innovation
by: Muhsin, Sayyed Mohamed
Published: (2024) -
Apex Pharma meeting challenges in the new millennium
by: Tan, Hing Tai
Published: (2000) -
Cash vs vouchers
by: Rahu, Sivaa Tangai
Published: (2022) -
College students vouch for the voucher
by: Anon
Published: (2011) -
No decision yet on book vouchers
by: Anon
Published: (2019)